Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles E. Smith is active.

Publication


Featured researches published by Charles E. Smith.


Annals of Internal Medicine | 1948

PATHOGENESIS OF COCCIDIOIDOMYCOSIS WITH SPECIAL REFERENCE TO PULMONARY CAVITATION

Charles E. Smith; Rodney R. Beard; Margaret T. Saito

Excerpt It is now accepted that human infections ofCoccidioides immitisare usually acquired by inhaling the chlamydospores and arthrospores of the fungus. Occasionally the portal of entry may be by...


The New England Journal of Medicine | 1980

Treatment of hirsute women with cimetidine.

Robert A. Vigersky; Ira Mehlman; Allan R. Glass; Charles E. Smith

THE treatment of hirsute women is controversial and often presents a therapeutic dilemma. Mechanical methods (such as shaving or using depilatories) are safe but often unacceptable to the patient, ...


Journal of Chronic Diseases | 1957

Serologic reactions in coccidioidomycosis.

Charles E. Smith; Margaret T. Saito

Abstract Coccidioidal serologie tests consist of a qualitative precipitin test and a quantitative complement fixation (C.F.) test. The antigens for each of these tests are appropriately standardized “Coccidioidins” comparable to that used for skin testing. The tests are relatively specific, though there is some irregular crossreaction in the other deep mycoses of histoplasmosis and probably blastomycosis. The tests detect better than 99 per cent of all coccidioidal infections which have undergone dissemination. Repeated tests can diagnose 90 per cent of symptomatic primary infections. However, even in symptomatic primary infections, failure to detect these diagnostic humoral antibodies does not rule out a coccidioidal diagnosis. They are frequently negative in patients with coccidioidal pulmonary residuals with and without cavitation. Unless a patients disease is undergoing dissemination, dermal sensitivity will be established during primary infection before the humoral antibodies have developed. Precipitins develop before complement-fixing antibodies and vanish sooner. Their presence connotes that the infection was acquired in the previous few months, although they may persist longer in patients with disseminated infections. Precipitins are of little diagnostic use in patients with asymptomatic pulmonary residuals or pulmonary cavities because of this time relationship. The titer of precipitins does not have prognostic significance. However, the quantitative determination of complement-fixing antibodies is very important prognostically. The more severe the infection, the higher the C.F. titer. Thus, in at least one-third of patients with primary infections which can be diagnosed serologically, only the precipitins will be positive. In those whose serum fixes complement, nearly half do so only in a 1:2 serum dilution and only 1 in 20 will fix it at a titer greater than 1:16 with the technique we use. However, over three-fifths of all those with disseminated disease exceed this titer as do ninetenths of those with extensive dissemination. With our technique this 1:16 serum dilution has proved to be a “critical” level. A rising titer is ominous, while a declining titer is reassuring. Complete fixation of complement by spinal fluid is diagnostic of coccidioidal meningitis and occurs in three-fourths of those with this dread complication. Because variations in C.F. techniques affect the titer, a positive serum control adjusted to the “critical” titer is needed as an index of comparison. Every effort is being made to develop such a material for the commercial distribution which should enable any competent clinical laboratory to perform the coccidioidal serologie tests.


Experimental Biology and Medicine | 1965

Antibodies in Human Coccidioidomycosis Immunoelectrophoretic Properties.

Demosthenes Pappagianis; Norma J. Lindsey; Charles E. Smith; Margaret T. Saito

Summary An immunoelectrophoretic study was undertaken on two types of antibody detectable in human coccidioidomycosis, early precipitins and later complement-fixing antibodies. By using concentrated precipitin sera and dilute coccidioidal antigen, arcs of precipitation were produced which appeared to correspond to the mobility of 19S β2 macro-globulin. Complement-fixing sera and cerebro-spinal fluids reacted with coccidioidal antigen to give precipitation arcs with the mobility of 7S γ2 globulin.


Mycopathologia Et Mycologia Applicata | 1957

The comparison of four strains of Coccidioides immitis with diverse histories.

Lorraine Friedman; Charles E. Smith

By the criterion of lethality in mice, a strain ofCoccidioides immitis recently isolated from a most devastating form of human coccidioidomycosis was of no greater virulence than another isolated from a much less severe case or even one cultured from soil fifteen years ago and which presumably had caused seven self-limited, benign cases of primary coccidioidomycosis. There was no enhancement of virulence to mice by twelve passages of a relatively avirulent strain which had been recovered twenty-one years ago from a fatal human case.


American Journal of Public Health | 1946

Varieties of Coccidioidal Infection in relation to the Epidemiology and Control of the Diseases.

Charles E. Smith; Rodney R. Beard


JAMA | 1956

PATTERN OF 39,500 SEROLOGIC TESTS IN COCCIDIOIDOMYCOSIS

Charles E. Smith; Margaret T. Saito; Susan A. Simons


American Review of Tuberculosis and Pulmonary Diseases | 1948

The use of coccidioidin.

Charles E. Smith; E. G. Whiting; E. E. Baker; H. G. Rosenberger; Rodney R. Beard; Margaret T. Saito


American Journal of Epidemiology | 1950

SEROLOGICAL TESTS IN THE DIAGNOSIS AND PROGNOSIS OF COCCIDIOIDOMPCOSIS

Charles E. Smith; Margaret T. Saito; Rodney R. Beard; Ruth McFADDEN Kepp; Ruth Wheatlake Clark; Bernice U. Eddie


JAMA | 1946

Effect of season and dust control on coccidioidomycosis.

Charles E. Smith; Rodney R. Beard; H. G. Rosenberger; E. G. Whiting

Collaboration


Dive into the Charles E. Smith's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. J. Berman

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Allan R. Glass

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge